BioMed Valley Discoveries Competitors and Similar CompaniesClear all
BioMed Valley Discoveries's competitors and similar companies include Gossamer Bio, Foghorn Therapeutics, Neovii and ImmPACT-Bio.
 BioMed Valley Discoveries BioMed Valley Discoveries is a clinical stage biotechnology company that specializes in difficult-to-treat diseases. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date 2007 | Founding Date 2015 | Founding Date 2016 | Founding Date 2003 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Kansas City, US HQ | Locations San Diego, US HQ Dublin 2, IE | Locations Cambridge, US HQ Cambridge, US | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 12 | Employees 11820% increase | Employees 1123% decrease | Employees 1193% increase | Employees 845% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 208 m | Valuation ($) 452 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($170.4m) (FY, 2025) | Net income ($74.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 480m | Total funding raised $ 50m | Total funding raised N/A | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Gossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View companyNeovii
HQ
Rapperswil-Jona, CH
Employees
119↑ 3% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company